Ethical Issues in New Drug Prescribing

This case study examines ethical and legal considerations physicians face when prescribing newly FDA-approved drugs, highlighting the limitations of both the drug approval system and post-approval surveillance mechanisms. The authors argue that physicians have ethical obligations to seek independent information sources, report adverse effects, and inform patients about the incomplete knowledge base surrounding new therapies.